CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$0.66
-0.03 (-3.91%)
Open$0.65
Previous Close$0.68
Day High$0.66
Day Low$0.62
52W High$3.70
52W Low$0.22
Volume—
Avg Volume2.15M
Market Cap61.48M
P/E Ratio12.75
EPS$-0.60
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+5,797.0% upside
Current
$0.66
$0.66
Target
$38.72
$38.72
$25.17
$38.72 avg
$55.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.60M | 17.28M | 16.86M |
| Net Income | 2.07M | 2.55M | 2.09M |
| Profit Margin | 11.8% | 14.8% | 12.4% |
| EBITDA | 4.18M | 3.81M | 3.82M |
| Free Cash Flow | 1.52M | 982.4K | 1.03M |
| Rev Growth | +11.2% | +9.6% | +9.9% |
| Debt/Equity | 0.55 | 0.54 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |